Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers

Recruiting now · Not applicable

Conditions studied: Endometrial Cancer

In brief

This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.

Key facts

Study ID

NCT04570553

Run by

WellSpan Health

People needed

350

Starts

2020-10-15

Expected to finish

2027-06-30

Last updated by the study team

2025-03-28

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subjects age 18 or older able to give informed consent
• Biopsy diagnosed endometrial cancer (including endometrioid, serous, mucinous and clear cell histologies)
• Planned standard of care surgical management of early stage endometrial cancer
• No clinical evidence of disseminated intraperitoneal disease

You may not qualify if…

• Final pathology does not reflect diagnosis of endometrial cancer (including endometrioid, serous, mucinous, and clear cell histology)
• Evidence of disseminated intraperitoneal disease
• Subject is not a surgical candidate
• Subject elects for fertility sparing or non-operative management
• Subject is unable to provide informed consent

Where it is running

• Wellspan Health — York, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.